Pacific Center for Emerging Infectious Diseases Research

太平洋新发传染病研究中心

• 批准号: 9098820
• 负责人: RICHARD YANAGIHARA
• 金额: $ 115.5万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-07-01 至 2020-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9098820
• 关键词: Accounting; Affect; Animals; Area; Asia; Avian Influenza; Award; Basic Science; Bioinformatics; Biological Sciences; Biomedical Research; Businesses; Cellular Immunology; Center for Translational Science Activities; Centers of Research Excellence; China; Clinical Research; Collaborations; Communicable Diseases; Communities; Data; Development; Diagnostic; Diagnostic tests; Ebola virus; Economics; Emerging Communicable Diseases; Ensure; Epidemic; Epigenetic Process; Extramural Activities; Faculty; Fostering; Foundations; Funding; Future Generations; Genetic; Goals; Grant; Growth; Guinea; Hawaii; Hawaiian population; Health; Health Services Research; Human; Infectious Diseases Research; Institution; International; Investments; Liberia; Mentors; Microbiology; Middle East Respiratory Syndrome Coronavirus; Mission; Modeling; Molecular Immunology; Monitor; Movement; National Institute of General Medical Sciences; Nutritional; Pacific Island Americans; Pakistan; Parasites; Phase; Poliomyelitis; Population Growth; Positioning Attribute; Prevention; Preventive Medicine; Principal Investigator; Productivity; Public Health; Recruitment Activity; Research; Research Infrastructure; Research Personnel; Research Priority; Resource Sharing; Resources; Science; Scientist; Sierra Leone; Speed; Stream; System; Therapeutic; Training; Training Support; Training and Education; Translational Research; Triad Acrylic Resin; Tropical Medicine; United States National Institutes of Health; Universities; Urbanization; Vaccines; base; biobehavior; disease diagnosis; ethnic disadvantage; ethnic minority population; graduate student; higher education; improved; microbial; next generation; novel vaccines; operation; programs; public health relevance; research and development; social; Accounting; Affect; Animals; Area; Asia; Avian Influenza; Award; Basic Science; Bioinformatics; Biological Sciences; Biomedical Research; Businesses; Cellular Immunology; Center for Translational Science Activities; Centers of Research Excellence; China; Clinical Research; Collaborations; Communicable Diseases; Communities; Data; Development; Diagnostic; Diagnostic tests; Ebola virus; Economics; Emerging Communicable Diseases; Ensure; Epidemic; Epigenetic Process; Extramural Activities; Faculty; Fostering; Foundations; Funding; Future Generations; Genetic; Goals; Grant; Growth; Guinea; Hawaii; Hawaiian population; Health; Health Services Research; Human; Infectious Diseases Research; Institution; International; Investments; Liberia; Mentors; Microbiology; Middle East Respiratory Syndrome Coronavirus; Mission; Modeling; Molecular Immunology; Monitor; Movement; National Institute of General Medical Sciences; Nutritional; Pacific Island Americans; Pakistan; Parasites; Phase; Poliomyelitis; Population Growth; Positioning Attribute; Prevention; Preventive Medicine; Principal Investigator; Productivity; Public Health; Recruitment Activity; Research; Research Infrastructure; Research Personnel; Research Priority; Resource Sharing; Resources; Science; Scientist; Sierra Leone; Speed; Stream; System; Therapeutic; Training; Training Support; Training and Education; Translational Research; Triad Acrylic Resin; Tropical Medicine; United States National Institutes of Health; Universities; Urbanization; Vaccines; base; biobehavior; disease diagnosis; ethnic disadvantage; ethnic minority population; graduate student; higher education; improved; microbial; next generation; novel vaccines; operation; programs; public health relevance; research and development; social

 DESCRIPTION (provided by applicant): Established in 2003, the Pacific Center for Emerging Infectious Diseases Research, a translational science center of excellence supported by funding from the Centers of Biomedical Research Excellence (COBRE) component of the Institutional Development Award (IDeA) program, seeks to develop and deploy rapid diagnostics, improved therapeutics and affordable vaccines for new, emerging and re-emerging infectious diseases that disproportionately affect underserved communities in the Asia-Pacific region. The COBRE Center also seeks to increase the diversity of the biomedical research workforce by training and mentoring native Hawaiians and other underrepresented Pacific Islanders. Thus, the Center's mission is thoroughly consistent with that of the National Institute of General Medical Sciences, which is to support basic research that lays the foundation for advances in disease diagnosis, treatment and prevention, and to increase the diversity of the research workforce by supporting the training of the next generation of scientists (http://www.nigms.nih.gov/About/Pages/default.aspx). The principal objective of the Phase III COBRE for emerging infectious diseases is to enhance the conditions that accelerate the pace of scientific discovery, heighten research productivity and increase competitiveness for extramural funding. The objective will be achieved by (1) enhancing the growth and sustainability of the COBRE cores in biocontainment, bioinformatics, and molecular and cellular immunology, which are grounded in the triad of customized and collaborative service, research and development, and education and training; and (2) developing and implementing a COBRE Small Grants Program, without borders, that fosters collaborations and partnerships, promotes data and resource sharing, and provides additional opportunities for mentoring and specialized training across IDeA-funded centers in research aimed at improving human health. COBRE funding during Phases I and II has transformed the landscape for mentoring and training future generations of investigators and has provided state-of-the-art core resources for multi-disciplinary collaborative research on epidemic infectious diseases. At the institutional level, COBRE funding has spurred significant commitments to recruit and retain a new cadre of productive faculty, and such efforts will continue into Phase III. High-level upper-administrative institutional commitments will ensure the sustainability of the Center and its cores beyond the Phase III COBRE period.

 描述（适用提供）：成立于2003年，太平洋新兴疾病中心是一个转化科学卓越中心，这是一个由生物医学研究卓越中心（COBRE）的资金支持的机构发展奖（IDEA）计划（IDEA）计划的资金，旨在开发和部署快速诊断的治疗，并提供新的治疗，并提供新的疾病，并提供新的疾病，并提供了新的疾病，并提供了新的疾病，并将其提供新的疫苗 - Emering，Emering，Emering，Emerging，Emerging，Emering，Emering，Emering，Emering，Emering，Emering，Emering，Emering，Emerysing，Emeringing，Emering，Emerysing，Emeringing，并寻求治疗疗法和REERING的治疗方法。不成比例地影响亚太地区服务不足的社区。该鞋垫中心还试图通过培训和心理夏威夷人和其他代表性不足的太平洋岛民来增加生物医学研究人员的多样性。这是该中心的使命与美国国家一般医学科学研究所的使命完全一致，该研究所支持基础研究，这是为疾病诊断，治疗和预防的进步基础，并通过支持下一代科学家的培训（http：/wwwwwwwww.nigms.nigms.nigms.nih.gov/pages/pages/deft/pages/deft/pages/deft/pagess/pagess/pagess）来增加研究劳动力的多样性。新兴疾病的第三阶段毛虫的主要目标是加快加速科学发现速度，提高研究生产力并提高壁外资金的竞争力的条件。该目标将通过（1）增强脚底核心在生物培养，生物信息学以及分子和细胞免疫学中的增长和可持续性，这些核心是基于定制和协作服务，研究与发展以及教育和培训的三合会的； （2）制定和实施一个无国界的毛cre小赠款计划，促进了合作和合作伙伴关系，促进数据和资源共享，并为跨越思想资助的研究中心提供了更多的精神和专业培训，旨在改善人类健康。第一阶段和第二阶段的田园经费改变了人们的心理和培训未来的研究人员的景观，并为多学科的流行传染病提供了最新的核心资源。在机构层面，柯布里的资金促使人们对招募和保留新的生产教师干部的重大承诺，这种努力将继续进入第三阶段。高级高级管理机构承诺将确保中心及其核心的可持续性超过第三阶段的毛球时期。